Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Heidari, Ramin ^a   Sadeghi, Masoumeh ^b   Talaei, Mohammad ^c   Rabiei, Katayoun ^b   Mohammadifard, Noushin ^b   Sarrafzadegan, Nizal ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Poursina Hakim Research Institute   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IRAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RURAL AREA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; WAIST CIRCUMFERENCE;

EID: 77957268229     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-59     Document Type: Article

References (29)

1. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. D Lloyd-Jones R Adams M Carnethon SG De TB Ferguson K Flegal, et al. Circulation 2009 119 3 480 6 10.1161/CIRCULATIONAHA.108.191259 19171871
2. Wing RRMenopause and risk factors for coronary heart disease. KA Matthews E Meilahn LH Kuller SF Kelsey AW Caggiula, N Engl Jour Med 1989 321 641 646 10.1056/NEJM198909073211004
3. The emergence of the metabolic syndrome with menopause. MC Carr, J Clin Endocrinol Metab 2003 88 6 2404 11 10.1210/jc.2003-030242 12788835
4. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). A Dorum S Tonstad AH Liavaag TM Michelsen B Hildrum AA Dahl, Gynecol Oncol 2008 109 3 377 83 10.1016/j.ygyno.2008.02.025 18407340
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 2001 285 19 2486 97 10.1001/jama.285.19.2486 11368702
6. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. HM Lakka DE Laaksonen TA Lakka LK Niskanen E Kumpusalo J Tuomilehto, et al. Jama 2002 288 21 2709 16 10.1001/jama.288.21.2709 12460094
7. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. M Royer C Castelo-Branco JE Blumel PA Chedraui L Danckers A Bencosme, et al. Climacteric 2007 10 2 164 70 10.1080/13697130701258895 17453865
8. The metabolic syndrome among postmenopausal women in Ecuador. LA Hidalgo PA Chedraui N Morocho M Alvarado D Chavez A Huc, Gynecol Endocrinol 2006 22 8 447 54 10.1080/09513590600890272 17012107
9. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. YW Park S Zhu L Palaniappan S Heshka MR Carnethon SB Heymsfield, Arch Intern Med 2003 163 4 427 36 10.1001/archinte.163.4.427 12588201
10. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. EA Petri Nahas NP Padoani J Nahas-Neto FL Orsatti AP Tardivo R Dias, Climacteric 2009 1 8
11. Metabolic syndrome after menopause and the role of hormones. RA Lobo, Maturitas 2008 60 1 10 8 10.1016/j.maturitas.2008.02.008 18407440
12. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. F Hadaegh H Harati A Ghanbarian F Azizi, East Mediterr Health J 2009 15 1 157 66 19469439
13. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. N Sarraf-Zadegan FA Sayed-Tabatabaei N Bashardoost A Maleki M Totonchi HR Habibi, et al. Acta Cardiol 1999 54 5 257 63 10596304
14. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. F Azizi P Salehi A Etemadi S Zahedi-Asl, Diabetes Res Clin Pract 2003 61 1 29 37 10.1016/S0168-8227(03)00066-4 12849921
15. Metabolic syndrome: an emerging public health problem in Iranian Women: Isfahan Healthy Heart Program. N Sarrafzadegan R Kelishadi A Baghaei G Hussein Sadri H Malekafzali N Mohammadifard, et al. Int J Cardiol 2008 131 1 90 6 10.1016/j.ijcard.2007.10.049 18190978
16. Isfahan Healthy Heart program: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. N Sarrafzadegan G Sadri H malek-Afzali, et al. Design, methods and initial experience. Acta Cardiol 2003 58 309 20
17. Metabolic syndrome pandemic. SM Grundy, Arterioscler Thromb Vasc Biol 2008 28 4 629 36 10.1161/ATVBAHA.107.151092 18174459
18. Appendix A. tables of energy requirements for activities of daily living, household tasks, recreational activities, and vocational activities. WA Dafoe, Clinical cardiac rehabilitation a cardiologist's guide Baltimore: Williams & Wilkins, Pashkow FJ, Dafoe WA, 2 1999 515 24
19. Physical activity patterns in a diverse population of women. B Sternfeld BE Ainsworth CP Quesenberry, Prev Med 1999 28 3 313 23 10.1006/pmed.1998.0470 10072751
20. CINDI: Countrywide Integrated Non-Communicable Diseases Interventional Programme: Protocol and Guidelines for Monitoring and Evaluation Procedures. E Leparki E Nussel, Berlin: Springer-Verlag 1987 73 82
21. Effect of a community-based intervention on nutritional behaviour in a developing country setting: the Isfahan Healthy Heart Programme. N Mohammadifard R Kelishadi M Safavi N Sarrafzadegan F Sajadi GH Sadri, et al. Public Health Nutr 2009 12 9 1422 30 10.1017/S1368980008004230 19220925
22. Menopause, energy expenditure, and body composition. ET Poehlman, Acta Obstet Gynecol Scand 2002 81 7 603 11 12190834
23. The metabolic syndrome in women. JG Schneider C Tompkins RS Blumenthal S Mora, Cardiol Rev 2006 14 6 286 91 10.1097/01.crd.0000233757.15181.67 17053375
24. Changes in body composition in women over six years at midlife: ovarian and chronological aging. M Sowers H Zheng K Tomey C Karvonen-Gutierrez M Jannausch X Li, et al. J Clin Endocrinol Metab 2007 92 3 895 901 10.1210/jc.2006-1393 17192296
25. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. I Janssen LH Powell S Crawford B Lasley K Sutton-Tyrrell, Arch Intern Med 2008 168 14 1568 75 10.1001/archinte.168.14.1568 18663170
26. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. CG Lee MC Carr SJ Murdoch E Mitchell NF Woods MH Wener WL Chandler, et al. J Clin Endocrinol Metab 2009 94 4 1104 10 10.1210/jc.2008-0701 19126626
27. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? KA Matthews SL Crawford CU Chae SA Everson-Rose MF Sowers B Sternfeld, et al. J Am Coll Cardiol 2009 54 25 2366 73 10.1016/j.jacc.2009.10.009 20082925
28. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). E Ainy P Mirmiran S Zahedi Asl F Azizi, Maturitas 2007 58 2 150 5 10.1016/j.maturitas.2007.07.002 17768019
29. Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan Healthy Heart Program. N Sarrafzadegan R Kelishadi A Baghaei G Hussein Sadri H Malekafzali N Mohammadifard, et al. Int J Cardiol 2008 131 1 90 6 10.1016/j.ijcard.2007.10.049 18190978